CLINICAL_TRIALS
trial_result
· 2026-04-21
Clinical Trial Update: Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use [Phase 4]
Summary
Phase 4 trial update evaluating the efficacy and tolerability of rimegepant for acute treatment of migraine in adults unsuitable for triptans.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2026-04-21